Amryt for Oleogel-s10 took CRL from the FDA in February 2022:
https://otp.tools.investis.com/clie...n/usnews-story.aspx?cid=1375&newsid=81548
I remind you that where Trofinetide counts (USA) is no longer ours, for Neuren I bet much more on 2591, for me at the moment a Takeover like Amryt's would be right, if instead it manages to be approved with Trofinetide and getting good results of phase 2 of 2591 I think we can even reach 2 billion usd, I don't even want to think about more, this is just my idea.
Amryt for Oleogel-s10 took CRL from the FDA in February 2022:...
-
- There are more pages in this discussion • 8,167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.57 |
Change
-0.040(0.26%) |
Mkt cap ! $1.990B | |||
| Open | High | Low | Value | Volume |
| $15.83 | $15.87 | $15.20 | $8.124M | 524.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 64 | $15.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.58 | 597 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |